{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:31:25Z","timestamp":1789140685365,"version":"build-2803163510"},"reference-count":17,"publisher":"SLACK, Inc.","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmic Surg Lasers Imaging Retina"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background and Objective<\/jats:title>\n                    <jats:p>This study evaluated treatment patterns and outcomes among patients with diabetic macular edema (DME) treated with the bispecific antibody faricimab in routine clinical practice in the United States.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods<\/jats:title>\n                    <jats:p>\n                      FARETINA-DME was a retrospective study among patients with DME initiating faricimab from February 2022 to June 2023 identified from the United States IRIS\n                      <jats:sup>\u00ae<\/jats:sup>\n                      Registry.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Four thousand five hundred fourteen (4,514) patients (6,204 eyes) previously treated with anti-vascular endothelial growth factor (anti-VEGF) therapy and 691 treatment-na\u00efve patients (851 eyes) were included. In previously treated eyes, mean \u00b1 SD visual acuity was 64.0 \u00b1 18.3 letters at index and 65.3 \u00b1 19.0 at faricimab injection 4. In treatment-na\u00efve eyes, visual acuity improved from 60.3 \u00b1 19.8 to 63.9 \u00b1 18.5 letters (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01). Mean \u00b1 SD central subfield thickness improved from 364.3 \u00b1 132.2 to 330.1 \u00b1 121.2 \u03bcm in previously treated eyes and 359.6 \u00b1 115.0 to 307.4 \u00b1 114.6 \u03bcm in treatment-na\u00efve eyes (both\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In patients with DME receiving faricimab, visual acuity was maintained in previously treated and improved in treatment-na\u00efve eyes. Both groups had anatomical improvement.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3928\/23258160-20250304-01","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T08:29:32Z","timestamp":1747297772000},"page":"478-486","source":"Crossref","is-referenced-by-count":9,"title":["Early Outcomes After Initiation of Faricimab in Patients With Diabetic Macular Edema"],"prefix":"10.3928","volume":"56","author":[{"given":"Durga S.","family":"Borkar","sequence":"first","affiliation":[{"name":"Duke University Eye Center, Durham, North Carolina;"},{"name":"Verana Health, San Francisco, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Tabano","sequence":"additional","affiliation":[{"name":"Genentech, Inc., South San Francisco, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferhina S.","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, New York Medical College, Valhalla, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore","family":"Leng","sequence":"additional","affiliation":[{"name":"Byers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Garmo","sequence":"additional","affiliation":[{"name":"Genentech, Inc., South San Francisco, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Genentech, Inc., South San Francisco, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Myers","sequence":"additional","affiliation":[{"name":"Verana Health, San Francisco, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline K.","family":"Shaia","sequence":"additional","affiliation":[{"name":"Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio;"},{"name":"Case Western Reserve University School of Medicine, Cleveland, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Barteselli","sequence":"additional","affiliation":[{"name":"Genentech, Inc., South San Francisco, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi P.","family":"Singh","sequence":"additional","affiliation":[{"name":"Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio;"},{"name":"Case Western Reserve University School of Medicine, Cleveland, Ohio;"},{"name":"Cleveland Clinic Martin Health, Cleveland Clinic Florida, Stuart, Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2308","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000003003"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-020-01377-x"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21145142"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201505889"},{"key":"e_1_3_2_6_2","volume-title":"Package insert","author":"Vabysmo","year":"2023","unstructured":"Vabysmo. Package insert. Genentech. 2023. https:\/\/www.gene.com\/download\/pdf\/vabysmo_prescribing.pdf"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00018-6"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2023.12.026"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-024-00525-9"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3181d87e04"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.2196\/medinform.4732"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.3390\/medici-na59040665"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo-2023-324394"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S381503"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S424314"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.64.13.31"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59061125"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2023.100442"}],"container-title":["Ophthalmic Surgery, Lasers and Imaging Retina"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T20:51:46Z","timestamp":1754945506000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/23258160-20250304-01"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.3928\/23258160-20250304-01"],"URL":"https:\/\/doi.org\/10.3928\/23258160-20250304-01","relation":{},"ISSN":["2325-8160","2325-8179"],"issn-type":[{"value":"2325-8160","type":"print"},{"value":"2325-8179","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]}}}